Sales rise 8.87% to Rs 864.85 crore
Net Loss of Strides Pharma Science reported to Rs 80.03 crore in the quarter ended December 2022 as against net loss of Rs 121.67 crore during the previous quarter ended December 2021. Sales rose 8.87% to Rs 864.85 crore in the quarter ended December 2022 as against Rs 794.39 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales864.85794.39 9 OPM %-3.13-2.86 -PBDT-59.36-54.81 -8 PBT-119.58-115.71 -3 NP-80.03-121.67 34Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content